Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Operant Conditioning Intervention01:24

Operant Conditioning Intervention

Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Behavior Therapy01:22

Behavior Therapy

Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protocol for an international multicenter randomized controlled trial assessing treatment success and safety of peroral endoscopic myotomy vs endoscopic balloon dilation for the treatment of achalasia in children.

PloS one·2023
Same author

Anaerobic Feces Processing for Fecal Microbiota Transplantation Improves Viability of Obligate Anaerobes.

Microorganisms·2023
Same author

Endoscopic Surveillance for Colorectal Cancer in Pediatric Ulcerative Colitis: A Survey Among Dutch Pediatric Gastroenterologists.

JPGN reports·2023
Same author

The Use of Pictograms in the Evaluation of Functional Abdominal Pain Disorders in Children.

The Journal of pediatrics·2023
Same author

Do Polymorphisms Predict Hypnotherapy Response in Children With Functional Abdominal Pain Disorders: An Explorative Study.

Journal of pediatric gastroenterology and nutrition·2023
Same author

Duration of Neonatal Antibiotic Exposure in Preterm Infants in Association with Health and Developmental Outcomes in Early Childhood.

Antibiotics (Basel, Switzerland)·2023

Related Experiment Videos

Behavioral therapy for childhood constipation: a randomized, controlled trial.

Marieke van Dijk1, Marloes E J Bongers, Giel-Jan de Vries

  • 1Psychosocial Department, Emma Children's Hospital, Academic Medical Center, Room G8-224, PO Box 22700, 1100 DE Amsterdam, The Netherlands. m.vandijk@amc.uva.nl

Pediatrics
|May 3, 2008
PubMed
Summary
This summary is machine-generated.

Behavioral therapy offers no significant advantage over conventional treatment for childhood constipation. However, it may reduce behavior problems in children with constipation.

Related Experiment Videos

Area of Science:

  • Pediatric Gastroenterology
  • Child Psychology

Background:

  • Functional constipation is common in children.
  • Behavioral interventions are proposed to improve continence in children with functional fecal incontinence associated with constipation.

Purpose of the Study:

  • To evaluate the clinical effectiveness of behavioral therapy combined with laxatives compared to conventional treatment for functional constipation in childhood.

Main Methods:

  • A randomized controlled trial was conducted with 134 children (aged 4-18 years) over 22 weeks.
  • Children were assigned to either behavioral therapy or conventional treatment.
  • Primary outcomes included defecation frequency, fecal incontinence frequency, and success rate; secondary outcomes included stool-withholding and behavior problems.

Main Results:

  • No significant differences were observed in defecation frequency, fecal incontinence frequency, or success rates between the two groups at the end of treatment or at 6-month follow-up.
  • The proportion of children withholding stools did not differ between interventions.
  • Behavioral therapy resulted in a significantly smaller proportion of children with behavior problems at follow-up.

Conclusions:

  • Behavioral therapy with laxatives shows no superiority over conventional treatment for childhood constipation.
  • Behavioral therapy may be beneficial for children with co-existing behavior problems.